- Home
- VRNT vs NEO Comparison
VRNT vs NEO Comparison
Compare VRNT & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- NEO
- Stock Information
- Founded
- VRNT 1994
- NEO 2001
- Country
- VRNT United States
- NEO United States
- Employees
- VRNT N/A
- NEO N/A
- Industry
- VRNT EDP Services
- NEO Precision Instruments
- Sector
- VRNT Technology
- NEO Health Care
- Exchange
- VRNT Nasdaq
- NEO Nasdaq
- Market Cap
- VRNT 1.2B
- NEO 1.1B
- IPO Year
- VRNT N/A
- NEO 1999
- Fundamental
- Price
- VRNT $20.26
- NEO $9.15
- Analyst Decision
- VRNT Hold
- NEO Buy
- Analyst Count
- VRNT 6
- NEO 10
- Target Price
- VRNT $25.60
- NEO $12.56
- AVG Volume (30 Days)
- VRNT 1.7M
- NEO 3.0M
- Earning Date
- VRNT 09-02-2025
- NEO 10-28-2025
- Dividend Yield
- VRNT N/A
- NEO N/A
- EPS Growth
- VRNT 10.62
- NEO N/A
- EPS
- VRNT 0.74
- NEO N/A
- Revenue
- VRNT $893,843,000.00
- NEO $689,189,000.00
- Revenue This Year
- VRNT $7.73
- NEO $10.40
- Revenue Next Year
- VRNT $5.67
- NEO $10.11
- P/E Ratio
- VRNT $27.49
- NEO N/A
- Revenue Growth
- VRNT N/A
- NEO 9.70
- 52 Week Low
- VRNT $14.15
- NEO $4.72
- 52 Week High
- VRNT $34.80
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- VRNT 51.22
- NEO 67.00
- Support Level
- VRNT $20.25
- NEO $7.56
- Resistance Level
- VRNT $20.30
- NEO $9.24
- Average True Range (ATR)
- VRNT 0.04
- NEO 0.36
- MACD
- VRNT -0.01
- NEO 0.06
- Stochastic Oscillator
- VRNT 42.10
- NEO 92.86
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.